A lot to digest here. Share market reaction is brutal (down ~20% after open), but there's some context to be aware of.
Starting with the results:
Total revenue for the 6 moths to December 31 was 25% higher at 61.1m. However, exlcuding the contribution from the recent Noventus Acquisition, revenue was essentially flat from the previous corresponding period.
(In saying that, it looks like that acquisition is working out well -- they paid only $5.7m for that business last year, which was generating $17.5m in full year revenues and 2.1m in EBITDA)
Reduced gross margins and operating margins resulted in a 5.3% decrease in EBITDA to $12.5m
Although none of this sounds great, Citadel has clearly articulated it's strategic shift towards its software segment -- which has lower margins than services revenue, but longer durations. And in this segment, revenue was up 18%. The Noventus business also operates at lower margins, which impacts the group average.
Post the Wellbeing acquisition (detailed in another Straw), the group expects 63% of total revenues to come from the Software segment, up from 47%
The company reiterated guidance of revenue and EBITDA growth for the full year, with ex-Noventus margins "broadly consistent". Specifically, revenue of $128-132m and EBITDA of $28-30m for the existing business.
On a pro-forma basis, including Wellbeing for a full year, FY20 group revenues and EBITDA would be $163.1m and $42.9m, respectively.
The purchase of Wellbeing is expected to be EPS accretive in FY20 and FY21, growing at upper single digit rates.
Although shares dropped significantly on the open, it's really just lost the last few weeks of gains, and remain above the issue price of new shares (for Wellbeing acquisition, of $4.65, a 12.5% discount to the 10-day volume weighted average price.
I still remain optimistic towards Citadel and hold on my Strawman scorecard.